J Immunol. 2007 Oct 1;179(7)
Cutting edge: An in vivo requirement for STAT3 signaling in TH17 development and TH17-dependent autoimmunity
Mol Cancer Res. 2007 Aug;5(8)
Activated signal transducers and activators of transcription 3 signaling induces CD46 expression and protects human cancer cells from complement-dependent cytotoxicity
J Immunother. 2007 Feb-Mar;30(2)
Stat3 as a potential target for cancer immunotherapy
Nat Rev Immunol. 2007 Jan;7(1)
Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment
Nat Med. 2005 Dec;11(12)
Inhibiting Stat3 signaling in the hematopoietic system elicits multicomponent antitumor immunity
Mol Cell Biol. 2005 Sep;25(17)
Role of Stat3 in regulating p53 expression and function
Oncogene. 2005 Aug 25;24(36)
Targeting Stat3 blocks both HIF-1 and VEGF expression induced by multiple oncogenic growth signaling pathways
Cancer Metastasis Rev. 2005 Jun;24(2)
Targeting STAT3 affects melanoma on multiple fronts
J Immunol. 2005 Apr 1;174(7)
Stat3 activity in melanoma cells affects migration of immune effector cells and nitric oxide-mediated antitumor effects
Cancer Res. 2004 Dec 15;64(24
Elimination of hepatic metastases of colon cancer cells via p53-independent cross-talk between irinotecan and Apo2 ligand/TRAIL
Mol Cancer Ther. 2004 Dec;3(12)
Inhibition of constitutive signal transducer and activator of transcription 3 activation by novel platinum complexes with potent antitumor activity
Nat Med. 2004 Jan;10(1)
Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells